Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Nanocarriers as an emerging platform for cancer therapy

2007 • 8,023 citations

Recent advances with liposomes as pharmaceutical carriers

2005 • 4,834 citations

Nanoparticle therapeutics: an emerging treatment modality for cancer

2008 • 3,976 citations

Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

2009 • 2,945 citations

Delivering nanomedicine to solid tumors

2010 • 2,903 citations

Collagens—structure, function, and biosynthesis

2003 • 2,293 citations

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

2006 • 1,697 citations

Molecular mechanisms of drug resistance

2005 • 1,510 citations

Role of extracellular matrix assembly in interstitial transport in solid tumors.

2000 • 1,126 citations

Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome

2008 • 822 citations

Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

2003 • 820 citations

Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

2007 • 646 citations

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

2009 • 584 citations

Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

2001 • 576 citations

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

1998 • 551 citations

A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

2006 • 541 citations

Diffusion and Convection in Collagen Gels: Implications for Transport in the Tumor Interstitium

2002 • 519 citations

Transforming growth factor-β in cancer and metastasis

2006 • 500 citations

Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

2001 • 467 citations

Angiotensin receptors: a new role in cancer?

2005 • 422 citations

Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

1994 • 421 citations

Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic Cardiomyopathy

2001 • 377 citations

Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector

2006 • 377 citations

Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-β–Independent Mechanism

2005 • 314 citations

Extravascular diffusion in normal and neoplastic tissues.

1984 • 294 citations

The renin-angiotensin system and malignancy

2008 • 288 citations

Renal injury due to renin–angiotensin–aldosterone system activation of the transforming growth factor-β pathway

2006 • 285 citations

Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–β–Dependent and –Independent Smad Pathways

2009 • 248 citations

Clinical Pharmacokinetics of Losartan

2005 • 239 citations

Tumor Blood Flow-Characterization, Modifications, and Role in Hyperthermia

1984 • 226 citations

Angiotensin receptor antagonists: focus on losartan

1995 • 214 citations

Relaxin Expression From Tumor-Targeting Adenoviruses and Its Intratumoral Spread, Apoptosis Induction, and Efficacy

2006 • 202 citations

Regression of Renal Vascular and Glomerular Fibrosis

2003 • 190 citations

AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist

2009 • 160 citations

Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis.

2002 • 159 citations

Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth

2004 • 149 citations

Matrix Metalloproteinases-1 and -8 Improve the Distribution and Efficacy of an Oncolytic Virus

2007 • 140 citations

Distribution of Extracellular Matrix Proteins in Pancreatic Ductal Adenocarcinoma and Its Influence on Tumor Cell Proliferation in Vitro

1987 • 138 citations

Neutralization of transforming growth factor-β attenuates hypertension and prevents renal injury in uremic rats

2005 • 137 citations

Pancreatic Cancer: Pathobiology, Treatment Options, and Drug Delivery

2010 • 118 citations

Antihypertensives as Novel Antineoplastics: Angiotensin-I-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Pancreatic Ductal Adenocarcinoma

2007 • 109 citations

Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice

2007 • 93 citations

Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors

2010 • 84 citations

Angiotensin converting enzyme inhibitors for cancer treatment?

2004 • 79 citations

Angiotensin inhibition and malignancies: a review

2009 • 79 citations

Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.

1993 • 75 citations

Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure.

1993 • 58 citations

Effects of Angiotensin II Subtype 1 Receptor Blockade by Losartan on Tubulointerstitial Lesions Caused by Hyperoxaluria

2002 • 58 citations

Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma

2009 • 55 citations

Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities

2009 • 48 citations

Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval

2010 • 46 citations

ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONIST (LOSARTAN) DOWN-REGULATES TRANSFORMING GROWTH FACTOR-β IN EXPERIMENTAL ACUTE PYELONEPHRITIS

2000 • 26 citations